Feel for those invested long term atm, as the ID hype drew a few in. It will come good though but patience is the key. (as with all bio's) I know you cannot compare companies, but as I mentioned yesterday this is about apples and pears. Selling at the market. IMM has it's stall set up and SCLP are still waiting to harvest them. That is not to say that IMM's fruit will be any sweeter. Give up your 10k shares and buy more IMM. We need a nudge. I have it on good authority that the current Mrs LeMoore agrees.
glad I recycled my SCLP by buying some more IMM shares. I can see SCLP dropping back to near the recent placement price. Investors seem to want instant gratification nowadays, if not then they quickly move on. I can see a good investment opportunity when the sp settles before any significant news.
hamila, have to agree, it would be better for shareholder value if that occurs. That said, after reading and re reading last weeks RNS then it would suggest their intention is clear. Torreya have been engaged for a reason. Their website makes interesting reading. If we get any further updates on IPP ...106 before any deal then we will be in a fantastic position. Imo this will completely derisk the shares.
So for a bit of fun (and not to be taken as gospel as the price is the price that the IMM board accept) on a grey, damp morning what do we all think would be an appropriate takeover price for IMM currently? And if anyone's especially brave what about 2-3 years down the line?
Interesting article here by US Congresswoman E Johnson. She states the US currently spends $31.4 billion treating Lupus patients each year and talks about the need for new treatments. She is joining an awareness campaign which seems to be a pressure group within Congress to raise awareness and seek new treatments. All good for Lupuzor
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.